Frank D Morrow

Frank D Morrow, Ph.D. FACN Pharma central laboratory and contract research executive serving the drug development and biotechnology industries.Atlanta, GA · http://www.linkedin.com/in/fdmorrow

Frank D Morrow's Bio:

Frank D Morrow's Experience:

• Managing Partner at InterPharm Scriptus, Inc.

  2007 - Present | Atlanta, GA

  Provides technical and management consulting services to the pharmaceutical central laboratory, clinical laboratory, and biopharmaceutical industries; Professional writing services for pharmaceutical, medical device, CRO and central laboratory firms including white papers, investigator site materials, technical monographs, standard operating procedures and instructional manuals; Preparation of new venture and strategic business plans, reports directed to the investment community or venture capital groups, management consultant reports, and solutions-oriented sales presentations

• Chief Operating Officer at LabConnect LLC

  August 2009 - July 2010

  Overall operational responsibility for global laboratory services firm providing support to pharmaceutical and biotechnology clients within the drug and biologics sectors; Established comprehensive interlaboratory harmonization program to standardize clinical laboratory results and data produced by virtual laboratory network serving clinical trial clients; Expanded company’s network to include leading clinical laboratories in China, South Korea and South Africa

• Vice President, Global Operations & Systems Integration at Quest Diagnostics Clinical Trials

  December 2003 - March 2007

  Responsible for all aspects of clinical trial business unit's global operation including specimen logistics, electronic reporting, project management, data services and clinical laboratory testing in support of sponsored clinical trials. Provided overall strategic direction for the clinical trial business unit with emphasis on the integration of biomarkers into company's service offering; Identification of acquisition targets for company's M&A strategy resulting in acquisition of a leading biomarker services company (December 2008). Used e-bidding and collection center consolidation to lower courier transportation costs - saved clinical trial clients > $12M annually; Executed expansion of company's proprietary and partnership laboratory facilities to People's Republic of China and to the Mideast resulting in expanded client access to major new patient populations; Oversaw application of Six Sigma to more than a dozen processes across the clinical trials business unit resulting in $9M savings annually.

• President & Chief Scientific Officer at Quintiles Laboratories

  November 1991 - September 2000

  Founding chief executive of Quintiles Laboratories, Ltd., the central laboratory division of Quintiles Transnational Corporation; Grew Quintiles Laboratories (QLAB) from business plan to network of 7 owned and partnership laboratories worldwide with an annual turnover of $110M and complete P&L responsibility; As the CSO was responsible for ensuring scientific integrity of the client's central laboratory regulatory submissions, provided scientific affairs oversight to GM's for each of the five central laboratory facilities worldwide; represented sponsor before review committees at the FDA and EMEA; Designed and developed QLIMS™ - the LIMS system used by Quintiles Laboratories to capture and report clinical trial data to its clients worldwide Designed and deployed QNET™ - a revolutionary remote access clinical project management application used by more than 250 pharmaceutical firms worldwide; Established the first commissions-based business development team ever to be deployed by Quintiles Transnational Corporation and leveraged "industry-best" business development professionals to ensure at least 40% year-end growth for each of nine years in succession; Gained experience at business operations in the international environment including Europe, Asia, Australia, South Africa and South America and the Peoples Republic of China.

• Adjunct Assistant Professor at Tufts University School of Nutrition

  July 1985 - November 1991

  Conducted original clinical research on human volunteers housed in 24-bed metabolic research unit; Lectured on clinical nutrition and analytical biochemistry at Tufts Medical School; Published original research in peer-reviewed scientific journals.

• Research scientist and Director, Nutrition Evaluation Laboratory at USDA Human Nutrition Research Center on Aging

  June 1984 - November 1991

  Conducted research related to the automation of laboratory methodologies for assessment of nutritional status in humans; Conducted research involving human subjects that established the nation’s RDAs for vitamins B12, B1 and B6.

• Chief Executive Officer at TROSS Laboratories Ltd, Moscow & Atlanta

  September 2010

  A new Pharmaceutical central laboratory, warehousing and drug distribution venture located in Moscow, Russian Federation and which is currently in the post-funding startup phase. Planned future offices for project services and data management will be located in Atlanta, GA and in the U.S. northeast drug corridor (NJ, PA and NY). TROSS Laboratories will be the first central laboratory in Russia and the CIS to meet all applicable FDA, EMEA and ISO regulatory, quality and accreditation requirements and guidelines.

Frank D Morrow's Education:

• Boston University - School of Management

  1984 – 1985
  MBA (ABD)

• Harvard University School of Public Health

  1983 – 1984
  Post-Doctoral Research
  Concentration: Clinical Nutrition (Diabetes)

• The University of Georgia

  1980 – 1983
  Ph.D.
  Concentration: Nutritional Biochemistry

• Penn State University

  1975 – 1980
  M.S.
  Concentration: Human Physiology, Exercise Physiology

• Shippensburg University of Pennsylvania

  1971 – 1975
  BA
  Concentration: Biology, Chemistry

Frank D Morrow's Interests & Activities: